The effects of oral and intravenous direct thrombin inhibitors on the size of photochemically induced cortical infarction in rats

被引:11
作者
Mikulski, A [1 ]
Elg, M [1 ]
Gustafsson, D [1 ]
机构
[1] AstraZeneca R&D, Dept Cardiovasc Pharmacol, S-43143 Molndal, Sweden
关键词
melagatran; thrombin inhibitor; ischaemic stroke; spontaneously hypertensive rats; rose bengal;
D O I
10.1016/S0049-3848(01)00209-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oral thrombin inhibitors are under development as potential drugs for prophylaxis and treatment of thrombotic events. The effect of pretreatment with two direct thrombin inhibitors, melagatran and inogatran, was evaluated in a rat model of cerebral infarction. Ischaemic stroke was induced by photochemical reaction after an injection of Rose Bengal and focused posterior and to the right of the intersection of the coronal and sagittal sutures on the intact calvarium. A single oral dose of melagatran (30 mu mol/kg) significantly reduced the volume of the cortical infarct by 53% (P <.05) compared with control. In addition, following intravenous inogatran (6 <mu>mol/kg) or oral inogatran (100 mu mol/kg), the volume of the cortical infarct decreased by 83% and 19%, respectively, compared with control. This study showed that experimental focal ischaemic infarction, elicited by photochemically induced endothelial cell damage, can be significantly reduced with melagatran and inogatran, direct thrombin inhibitors. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:477 / 482
页数:6
相关论文
共 18 条
[1]  
ASTRA AB, 1994, Patent No. 9429336
[2]   ARGATROBAN, A SELECTIVE, POTENT THROMBIN INHIBITOR [J].
BUSH, LR .
CARDIOVASCULAR DRUG REVIEWS, 1991, 9 (03) :247-263
[3]  
DERYCK M, 1990, EUR NEUROL, V30, P21
[4]  
DUVERGER D, 1985, J CEREB BLOOD FLOW M, V5, P415
[5]  
Elg M, 1997, THROMB HAEMOSTASIS, V78, P1286
[6]   A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement [J].
Eriksson, BI ;
WilleJorgensen, P ;
Kalebo, P ;
Mouret, P ;
Rosencher, N ;
Bosch, P ;
Baur, M ;
Ekman, S ;
Bach, D ;
Lindbratt, S ;
Close, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) :1329-1335
[7]  
Eriksson UG, 1998, BIOPHARM DRUG DISPOS, V19, P55, DOI 10.1002/(SICI)1099-081X(199801)19:1<55::AID-BDD74>3.0.CO
[8]  
2-H
[9]  
Foote C.S., 1976, FREE RADICALS BIOL, V11, P85, DOI DOI 10.1016/B978-0-12-566502-5.50010-X
[10]  
Gustafsson D, 1998, THROMB HAEMOSTASIS, V79, P110